Juan Macías
0000-0002-4778-790X
199 papers found
Refreshing results…
A genome‐wide association study on low susceptibility to hepatitis C virus infection (GEHEP012 study)
Response to direct-acting antiviral therapy among ongoing drug users and people receiving opioid substitution therapy
Similar recovery of liver function after response to all-oral HCV therapy in patients with cirrhosis with and without HIV coinfection
Early emergence of opportunistic infections after starting direct-acting antiviral drugs in HIV/HCV-coinfected patients
Practical steps to improve chronic hepatitis C treatment in people with opioid use disorder
Impact of interferon-free regimens on the glomerular filtration rate during treatment of chronic hepatitis C in a real-life cohort
Integrated Hepatitis C Care for People Who Inject Drugs (Heplink): Protocol for a Feasibility Study in Primary Care (Preprint)
Bacterial translocation and clinical progression of HCV-related cirrhosis in HIV-infected patients
Hepatitis C virus core antigen in the management of patients treated with new direct-acting antivirals
Changes in Liver Steatosis After Switching From Efavirenz to Raltegravir Among Human Immunodeficiency Virus-Infected Patients With Nonalcoholic Fatty Liver Disease.
Fat mass and obesity-associated gene variations are related to fatty liver disease in HIV-infected patients.
Week 4 response predicts sustained virological response to all-oral direct-acting antiviral-based therapy in cirrhotic patients with hepatitis C virus genotype 3 infection
Low incidence of acute hepatitis C virus infection among Southern Spanish HIV-infected individuals
Liver stiffness predicts the response to direct-acting antiviral-based therapy against chronic hepatitis C in cirrhotic patients.
Liver stiffness predicts variceal bleeding in HIV/HCV-coinfected patients with compensated cirrhosis:
Non-Alcoholic Fatty Liver Disease in HIV Infection.
High frequency of potential interactions between direct-acting antivirals and concomitant therapy in HIV/hepatitis C virus-coinfected patients in clinical practice
Common haplotypes in CD209 promoter and susceptibility to HIV-1 infection in intravenous drug users
Changes in the response to treatment against chronic hepatitis C between 1999 and 2015
HLA-B18 as risk factor of liver fibrosis progression in HIV/HCV treatment-experienced patients
Missing publications? Search for publications with a matching author name.